Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Tirzepatide for Sale > High-quality Tirzepatide Lyophilized Powder
High-quality Tirzepatide Lyophilized Powder buy - large image1
High-quality Tirzepatide Lyophilized Powder buy - image1
High-quality Tirzepatide Lyophilized Powder buy - image2
High-quality Tirzepatide Lyophilized Powder buy - image3
High-quality Tirzepatide Lyophilized Powder buy - image4
High-quality Tirzepatide Lyophilized Powder buy - image5
High-quality Tirzepatide Lyophilized Powder buy - image6

High-quality Tirzepatide Lyophilized Powder

TDS 2101 Inquiries

Unit Price: Get Latest Price
CAS No.:

2023788-19-2

Grade:

Laboratory Grade

Content:

99%

Port:

广州

Brand:

Boruimei

Packaging:

5mg*10vials, 10mg*10vials, 15mg*10vials, 20mg*10vials, 30mg*10vials, 40mg*10vials, 60mg*10vials

Price valid (until):

2026-06-10

The product will be displayed normally on the website later.
Company Type:
Trader
Location:
China
Qualification:
Main Products:

Polypeptide Products

  • Product Details

  • Seller Information

  • Inquiry History

  • Description
    Items Specifications
    Product Name Tirzepatide
    CAS No. 2023788-19-2
    Molecular Formula C₂₂₅H₃₄₈N₄₈O₆₈
    Molecular Weight 4813.4
    Purity ≥99% (HPLC)
    Appearance White to off-white lyophilized powder
    Grade Pharmaceutical Grade / API
    Storage -20°C, sealed, dry, protected from light
    Shelf Life 24 months under proper storage
    Country of Origin China


    Contact Us


    NAME: Jeck Moss
    WHATSAPP:+852 5575 6971
    TELEGRAM:+852 5575 6971
    EMAIL:sales@boruimei.com
    Welcome to concult


      Product Detail  


    Tirzepatide is a novel, long-acting dual GIP/GLP-1 receptor agonist developed for glycemic control and weight management. It is a 39-amino-acid synthetic peptide conjugated with a C20 fatty diacid, exhibiting high potency and prolonged half-life for once-weekly administration.

    Shop High-quality Tirzepatide Lyophilized Powder-Detailed Image 1

    Key Benefits

    • -Dual-action: Activates both GIP and GLP-1 receptors, superior to single GLP-1 agonists in glucose regulation and weight loss.
    • -Long half-life: ~5 days, supporting once-weekly dosing for better compliance.
    • -High purity: ≥99% HPLC, low impurities, suitable for research and formulation.
    • -Well-documented: FDA approved (May 2022) and EU approved (Sep 2022) for type 2 diabetes; also indicated for chronic weight management.

    Applications

    • Pharmaceutical API: For research, custom synthesis, and formulation development.
    • Research use: Diabetes, obesity, metabolic disorder studies.
    • Lab reagent: Analytical standard, reference substance.

    Specifications

    • Purity: ≥99% (HPLC)
    • Peptide Content: ≥98%
    • Water Content: ≤5%
    • Residual Solvents: Meet ICH Q3C
    • Endotoxin: ≤10 EU/mg

    Package & Delivery

    • Packing: 5mg*10vials, 10mg*10vials, 15mg*10vials, 20mg*10vials, 30mg*10vials, 40mg*10vials, 50mg*10vials, 60mg*10vials, 100mg*10vials, 120mg*10vials

      Shop High-quality Tirzepatide Lyophilized Powder-Detailed Image 2
    • Lead time: In stock, 3–5 working days after payment.
    • Documents: COA, HPLC, MS, TDS, SDS available upon request.

    Quality Assurance

    • Strict QC: HPLC, MS, moisture, residual solvents, endotoxin.
    • GMP-like production environment, traceable batch records.
    • Custom synthesis and bulk supply supported.


    Why Choose Us


    • 1.High quality products with competitive pricing.
    • 2.Free samples available for your evaluation and testing.
    • 3.Fast, reliable delivery via reputable shipping lines.
    • 4.Trial orders are welcome for quality verification after sample approval.
    • 5.Proactive updates and full transparency at every stage of your order.
    • 6.Custom packaging solutions tailored to meet your specific requirements.


    Shop High-quality Tirzepatide Lyophilized Powder for Fitness and Weight Loss-Detailed Image 3


      Our factory


    Shop High-quality Tirzepatide Lyophilized Powder for Fitness and Weight Loss-Detailed Image 4 Shop High-quality Tirzepatide Lyophilized Powder for Fitness and Weight Loss-Detailed Image 5 Shop High-quality Tirzepatide Lyophilized Powder for Fitness and Weight Loss-Detailed Image 6


      How to order  


    Shop High-quality Tirzepatide Lyophilized Powder for Fitness and Weight Loss-Detailed Image 7


      Delivery time  


    • USA: 7-12days (tax included)

    • Europe: 7–12 days (tax included)

    • Australia: 7–12 days (tax included)

    • Canada: 7–12 days (tax included)

    • Asia and Southeast Asia: 5–10 days (tax included)

    • Free redelivery is available if the parcel fails to arrive on time.

    FAQ

    1.Can we get your free samples?

    Yes, can. Our free sample can be provided for customers test. But the freight for express is obuyer's account.

    2.Can we do printing or label on the bottles?

    Yes, can. We can offer various printing ways,such, screen printing, hot stamping, label printing.

    3.What is the normal lead time?

    For stock products, within 24-48 hours after we receive your payment. For smaller customize color bottles, we will ship out within 3-5 days.

    4.What is your shipping terms?

    Faster ways: FEDEX, DHL, UPS, TNT, etc by sea or by air economy

    5.How does your factory do regarding quality control?

    We do test for 3 times before packing.

    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Certificates

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Polypeptide Products

    Location:

    No. 917, 9th Floor, Unit 1, Building 19, Shengshi Huayuan Business Center, Shunhua Road Sub-district, High-tech Zone, Jinan City, Shandong Province

    Total Annual Revenue:

    Less than $1 million

    Total Employees:

    5-10

    Year of Establishment:

    2026

  • Inquiry History
    2101 Inquiries
    Country Product Purchase Quantity Date Posted
    Brazil

    Tirzepatide

    100 G Oct 28, 2026
    Belgium

    Tirzepatide

    10 MG Oct 28, 2026
    United States

    tirzepatide

    100 MG Oct 28, 2026
    United States

    Tirzepatide

    60 MG Oct 28, 2026
    United States

    Tirzepatide

    10 PCS Oct 28, 2026
    United States

    tirzepatide

    30 MG Oct 27, 2026
    United States

    Tirzepatide

    40 MG Oct 27, 2026
    Philippines

    Tirzepatide

    2 MT Oct 27, 2026
    Philippines

    Tirzepatide

    30 MG Oct 26, 2026
    Slovakia

    Tirzepatide

    1 G Oct 26, 2026
    France

    Tirzepatide

    1 KG Oct 25, 2026
    United States

    Tirzepatide

    2.5 MG Oct 25, 2026
    United Kingdom

    Tirzepatide

    5 MT Oct 25, 2026
    United Kingdom

    Tirzepatide

    6 MT Oct 24, 2026
    Peru

    tirzepatide

    10 MG Oct 21, 2026
    Puerto Rico

    tirzepatide

    40 MG Oct 21, 2026
    United States

    Tirzepatide

    10 MT Oct 21, 2026
    South Africa

    Tirzepatide

    1 MT Oct 20, 2026
    United States

    Tirzepatide

    5 KG Oct 20, 2026
    United States

    tirzepatide

    30 MG Oct 20, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.